List of insiders holdings for Kiniksa Pharmaceuticals International plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 2026-06-02 16:30:37 | 29,680 2,817,842 | 2,847,522 | Form 4 |
| 2 | Patel Sanj K CHAIRMAN & CEO | 2026-06-02 16:50:02 | 0 1,763,923 | 1,763,923 | Form 4 |
| 3 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner | 2019-02-14 16:14:48 | 831,000 0 | 831,000 | Form 13G |
| 4 | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner | 2019-02-14 16:14:48 | 831,000 0 | 831,000 | Form 13G |
| 5 | BOESS CARSTEN 10% Owner | 2018-05-29 19:19:09 | 559,016 0 | 559,016 | Form 4 |
| 6 | Malley Thomas Director | 2026-06-02 16:46:38 | 29,529 71,967 | 101,496 | Form 4 |
| 7 | Paolini John F. CHIEF MEDICAL OFFICER | 2026-05-05 16:54:33 | 95,293 0 | 95,293 | Form 4 |
| 8 | Mahoney Stephen F. President & COO | 2019-09-19 16:18:37 | 82,000 0 | 82,000 | Form 4 |
| 9 | Heberlig Chris EVP & CFO | 2019-09-19 16:16:52 | 50,000 0 | 50,000 | Form 4 |
| 10 | Popovits Kimberly J Director | 2026-06-02 16:51:17 | 29,529 0 | 29,529 | Form 4 |
| 11 | McCain Tracey L Director | 2026-06-02 16:48:18 | 29,529 0 | 29,529 | Form 4 |
| 12 | Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-13 16:35:46 | 27,418 0 | 27,418 | Form 4 |
| 13 | Pano Arian Chief Clinical Dev. Officer | 2021-09-07 17:19:21 | 27,213 0 | 27,213 | Form 4 |
| 14 | Tessari Eben CHIEF STRATEGY OFFICER | 2026-04-08 16:45:11 | 23,130 0 | 23,130 | Form 4 |
| 15 | Levy Richard S Director | 2026-08-04 16:40:33 | 22,762 0 | 22,762 | Form 4 |
| 16 | Ragosa Mark CHIEF FINANCIAL OFFICER | 2026-04-08 16:44:12 | 16,154 0 | 16,154 | Form 4 |
| 17 | Quart Barry D Director | 2026-08-21 16:35:09 | 12,745 0 | 12,745 | Form 4 |
| 18 | Moat Ross CHIEF OPERATING OFFICER | 2026-04-13 16:34:42 | 12,029 0 | 12,029 | Form 4 |
| 19 | Beetham Thomas W. EVP & Chief Legal Officer | 2021-03-23 17:32:56 | 10,142 0 | 10,142 | Form 4 |
| 20 | Cole G Bradley Director | 2026-07-31 16:34:49 | 7,172 0 | 7,172 | Form 4 |
| 21 | Rizvi Qasim Chief Commercial Officer | 2021-01-05 17:07:03 | 5,176 0 | 5,176 | Form 4 |
| 22 | Boyd Meta Cantey Director | 2024-10-08 17:08:24 | 0 0 | 0 | Form 3 |
| 23 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | 2026-07-06 16:42:47 | 0 0 | 0 | Form 4 |
| 24 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. *Possible member of 10% group 10% Owner | 2020-02-13 12:42:47 | 0 0 | 0 | Form 13G |
| 25 | Biggar Stephen R Director | 2018-05-23 20:23:42 | 0 0 | 0 | Form 3 |